Help Shape the Roadmap for the Future of Data Validation

Health plans are operating in a complex and rapidly changing environment. As more clinical data streams become available for quality reporting and care management, challenges persist in measuring the quality of these new data sources. NCQA has been exploring ways to improve data quality while reducing reliance on manual data verification, including Primary Source Verification (PSV).

Earlier this year, NCQA launched our first product offering related to automated data quality assessment. We have been working with health IT vendors, health information exchanges and technology partners through a beta implementation program to test HEDIS^® Data Quality Specifications and emerging approaches to automated data quality assessment and validation.

This work is intended to support a future state in which data quality can be monitored continuously across the data lifecycle to transition away from PSV as a universal requirement for HEDIS reporting in MY 2027. As the organizations most affected by changes to HEDIS audit, validation and data confidence expectations, health plans play a critical role in helping define how the industry responsibly transitions to these new approaches.

That is why NCQA is launching a Health Plan Data Quality Convening to identify the operational realities, dependencies and safeguards needed to make this transition successful. Participants will play a critical role in defining the roadmap for the industry’s transition from current validation methods, such as PSV, to more automated, scalable approaches while maintaining trust in quality measurement and clinical data.

How the Data Quality Convening Works

The convening is intended to surface actionable insights that promote alignment across the industry and inform the roadmap for modernizing data validation and quality assurance.

Through facilitated, discussion-based sessions, organizations will share real-world experiences and collaborate to identify practical approaches that support more reliable, scalable and trusted data for quality measurement. The convening will:

• Explore what creates trust and reliability in digital quality data.
• Examine how continuous monitoring approaches could complement and ultimately replace retrospective validation models.
• Identify the operational, governance and ecosystem capabilities needed to support a reduction in PSV requirements.
• Inform a roadmap for how NCQA and the industry can responsibly transition to scalable, automated data quality monitoring.
• Help ensure future approaches reflect real-world health plan needs and constraints.

Participants will take part in three virtual sessions from August through November 2026, where they will share information about their organization’s approach to data quality. NCQA will treat all shared information as confidential.

Output of the Data Quality Convening

Insights from the convening, combined with results from ongoing beta testing of NCQA’s HEDIS Data Quality Specifications, will inform an industry roadmap that NCQA will publish later this year. The roadmap will outline how the industry can transition from retrospective validation to more continuous, automated data quality monitoring while maintaining trust and confidence in quality measurement.

How to Participate in the Convening

We are seeking participation from health plan leaders and subject matter experts involved in:

• Quality measurement, analytics and reporting.
• Data management, interoperability and implementation of Fast Healthcare Interoperability Resources (FHIR^®).
• Audit, primary source verification or validation.
• Clinical operations or related functions.

Participation will be limited to one primary representative per organization, with the option to designate an alternate representative.

Visit our website to learn more about the convening or to submit an application. Please email us if you have any questions about the convening or the application process.

HEDIS^® is a registered trademark of the National Committee for Quality Assurance (NCQA).

FHIR^® is a registered trademark of Health Level Seven International and its use does not constitute endorsement by HL7.